Advances in Regenerative Medicine (RM) and Gene Therapy
- How can Regenerative medicine and gene therapy ensure a better lifelong health and citizen’s wellbeing?
- What are the main benefits of the new frontiers this breakthrough holds in comparison to conventional medicine?
- How will the efforts made by governments balance the high initial research & development costs against the long-term cost benefits?
The future of regenerative medicine and gene therapy holds immense potential for transforming healthcare. As research and technological advancements continue to unfold, we can anticipate significant breakthroughs in this field.
Advancements in stem cell therapies, tissue engineering, and biomaterials will likely enable the regeneration and replacement of damaged tissues and organs, leading to improved treatment outcomes for conditions that were once considered incurable. Similarly, gene therapy is expected to make significant strides in addressing genetic disorders by targeting the underlying genetic causes. While challenges and ethical considerations remain, the future of regenerative medicine and gene therapy offers hope for personalized, targeted treatments and a new frontier in healthcare.
This paper examines the case for tapping into emerging sectors as an important source of economic growth and development, with examples of different countries and their approach to identifying new opportunities and capturing inherent economic value.
Over the past 25 years, education outcomes have stagnated globally, while the COVID-19 pandemic has exacerbated existing inequalities in the education system.
This report discusses how governments have evolved to, among other things, manage social contracts, and they play a central role in contemporary societies.